Tat-PCP

General Information


DRACP ID  DRACP05450

Peptide Name   Tat-PCP

Sequence  RKKRRQRRRXDEXLI

Sequence Length  15

UniProt ID  Not available

PubChem CID  Not available

Origin  Protein derived

Type  Native peptide

Classification

  

Cancer targeted peptides Membrane-targeted Cell-penetrating peptides



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Acetylation

C-terminal Modification  Amidation

Other Modification  Φ=L-2-naphthylalanine; X(10)=miniPEG, 8-amino-3,6-dioxaoctanoic acid; X(13)=Pcap, phosphocoumaryl aminopropionic acid

Chiral  L



Physicochemical Information


Formula  C74H136N34O17

Absent amino acids  ACFGHMNPSTVWY

Common amino acids  R

Mass  224399

Pl  12.51

Basic residues  8

Acidic residues  2

Hydrophobic residues  2

Net charge  6

Boman Index  -11185

Hydrophobicity  -246.67

Aliphatic Index  52

Half Life 
  /

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  0

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 24896852

Title  Not available

Doi Not available

Year  Not available

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




Cppsite ID  2249

DRACP is developed by Dr.Zheng's team.